Post Content
Related Posts
The Fed will update its rate projections Wednesday. Here’s what to expect
If market pricing is correct, there’s virtually no chance central bank policymakers budge from the current level of their key interest rate.
FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.
Europe’s banks brace for tougher competition under Trump 2.0
European banks face an even tougher task to close an earnings gap on U.S. rivals, as Wall Street awaits a new era of financial deregulation.